You have 9 free searches left this month | for more free features.

P50

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

EX-PRESS® P-50 and EX-PRESS® P-200

Not yet recruiting
  • Glaucoma
  • EX-PRESS P-50 filtration device
  • EX-PRESS P-200 filtration device
  • (no location specified)
Oct 31, 2023

Breast Cancer Trial in New York (Multicomponent Adherence Intervention)

Recruiting
  • Breast Cancer
  • Multicomponent Adherence Intervention
  • New York, New York
    Columbia University Medical Center
Nov 6, 2023

Based Care for Youth in Low-resource Environments

Recruiting
  • Improving Therapist Use of Measurement-based Care
    • Seattle, Washington
      KPWHRI
    Nov 30, 2022

    Schizophrenia Trial in Glendale, Rouffach, Toul (NSA-789 at 2 different doses)

    Withdrawn
    • Schizophrenia
    • NSA-789 at 2 different doses
    • Glendale, California
    • +2 more
    Aug 17, 2021

    Bioequivalence, Diabetes, Type 2 Trial in Mount Royal (Sitagliptin/Metformin HCl 50/850 mg film-coated tablet)

    Completed
    • Bioequivalence
    • Diabetes Mellitus, Type 2
    • Sitagliptin/Metformin HCl 50/850 mg film-coated tablet
    • Mount Royal, Quebec, Canada
      Algorithme Pharma
    Sep 20, 2022

    Bioequivalence, Type 2 Diabetes Trial in Mount Royal (Sitagliptin/metformin HCl (HCl) 50/1000 mg film-coated tablet)

    Completed
    • Bioequivalence
    • Type 2 Diabetes
    • Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet
    • Mount Royal, Quebec, Canada
      Algorithme Pharma
    Sep 20, 2022

    SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

    Recruiting
    • SARS-CoV-2 Infection
    • B/HPIV3/S-6P
    • Baltimore, Maryland
      Johns Hopkins Bloomberg School of Public Health
    Aug 30, 2023

    Schizophrenia Trial in Denver (Ondansetron followed by , Placebo followed by Ondansetron)

    Completed
    • Schizophrenia
    • Ondansetron followed by placebo
    • Placebo followed by Ondansetron
    • Denver, Colorado
      Denver VAMC
    Jul 20, 2021

    Bioequivalence Trial in Mount Royal (Lamotrigine ER tablet 50mg)

    Completed
    • Bioequivalence
    • Lamotrigine ER tablet 50mg
    • Mount Royal, Quebec, Canada
      Algorithme Pharma
    Dec 6, 2021

    Healthy Trial in Québec (Camlipixant + Gemfibrozil, Dabigatran etexilate + camlipixant)

    Not yet recruiting
    • Healthy
    • Camlipixant + Gemfibrozil
    • Dabigatran etexilate + camlipixant
    • Québec, Quebec, Canada
      Syneos Health
    Jul 17, 2023

    Healthy Trial in Québec (Camlipixant + Rifampin, Camlipixant + Rabeprazole)

    Not yet recruiting
    • Healthy
    • Camlipixant + Rifampin
    • Camlipixant + Rabeprazole
    • Québec, Quebec, Canada
      Syneos Health
    Jun 2, 2023

    Nasonex® Nasal Suspension 50 µg Long-term Designated Drug Use

    Completed
    • Allergic Rhinitis
    • mometasone furoate
    • (no location specified)
    Feb 7, 2022

    Healthy Trial in Mexico City (Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg, Pregabalin 150mg, Tramadol 50 mg)

    Completed
    • Healthy
    • Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg
    • +2 more
    • Mexico City, Mexico
      Laboratorio Silanes, S.A. de C.V.
    May 19, 2022

    Migraine Headache Trial (rizatriptan benzoate (MK0462), Comparator: sumatriptan, Comparator: Placebo)

    Completed
    • Migraine Headache
    • rizatriptan benzoate (MK0462)
    • +2 more
    • (no location specified)
    Feb 1, 2022

    Cervix Cancer, HPV Testing, Postmenopausal Women Trial in Randers (cytology, p16/ki67 dual stain cytology (DS), extended

    Recruiting
    • Cervix Cancer
    • +2 more
    • cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,
    • Randers, Central Denmark Region, Denmark
      Department of Pathology
    Feb 3, 2023

    Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul (PPI, P-CAB 25, P-CAB 50)

    Recruiting
    • Coronary Artery Disease
    • +3 more
    • Seoul, Korea, Republic of
      Asan Medical Center
    Mar 6, 2022

    Group A Streptococcal Infection Trial in Edmonton (p*17-K4S2 (25 µg/mL), J8-K4S2 (100 µg/mL), p*17-K4S2 (50 µg/mL))

    Not yet recruiting
    • Group A Streptococcal Infection
    • p*17-K4S2 (25 µg/mL)
    • +4 more
    • Edmonton, Alberta, Canada
      University of Alberta Hospital
    Jul 26, 2022

    Sickle Cell Disease Trial in Paris (Famotidine 400 mg/50 mL)

    Recruiting
    • Sickle Cell Disease
    • Famotidine 400 mg/50 mL
    • Paris, France
      Necker - Enfants malades Hospital; Department of Pediatrics and
    Oct 10, 2022

    Covid19 Trial in Ottawa (drug, dietary supplement, other)

    Suspended
    • Covid19
    • Vitamin D3 50,000 IU
    • +4 more
    • Ottawa, Ontario, Canada
      The Centre for Health Innovation
    Aug 8, 2022

    Drug Interaction Trial in Montréal (ATI-2173 50 mg, Tenofovir 300Mg Oral Tablet)

    Completed
    • Drug Interaction
    • ATI-2173 50 mg
    • Tenofovir 300Mg Oral Tablet
    • Montréal, Quebec, Canada
      Altasciences
    Feb 3, 2022

    Healthy Adults Trial in Dallas (Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole)

    Recruiting
    • Healthy Adults
    • Sitravatinib 50 mg
    • +3 more
    • Dallas, Texas
      Labcorp Drug Development Clinical Research Unit
    Feb 23, 2022

    Asthma Trial (mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID,

    Completed
    • Asthma
    • mometasone furoate combination MDI 200/10 mcg BID
    • +3 more
    • (no location specified)
    Feb 7, 2022

    COPD (COPD) Trial in Bordeaux (Seretide® Diskus® 500/550 µg, Ultibro® Breezhaler® 110/50 µg, Spiriva® Respimat® 2,5 µg)

    Completed
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Seretide® Diskus® 500/550 μg
    • +2 more
    • Bordeaux, France
      CIC-P - Centre François Magendie - G3 - Hôpital Haut-Lévêque
    Feb 8, 2022

    Sunburn, Sun Damaged Skin, Overexposure to Sun Rays Trial in Chile, Peru, United States (otc sunscreens, sun protection fabrics,

    Enrolling by invitation
    • Sunburn
    • +2 more
    • otc sunscreens
    • +2 more
    • San Diego, California
    • +4 more
    Oct 24, 2022

    Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

    Recruiting
    • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +10 more
    • Intensity-Modulated Radiation Therapy
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 8, 2022